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osteoarthritis (K-OA). A previous study suggested a slowdown of type II
collagen degradation after VS as evidenced by a signiﬁcant of urine type
II collagen C telopeptide. To investigate in K-OA patients the effect of VS
on type II collagen degradation using serum Coll2–1, a peptide located
in triple helical part of type II collagen molecule, and its nitrated form
Coll2–1NO2.
Methods: Prospective open label study. 51 patients with unilateral
symptomatic K-OA (ACR criteria; Kellgren-Lawrence grade (KL) II to IV)
received an IA injection of 2ml of HA (hylan GF-20 a high molecular
weight cross-linked HA derivative) on days (D) 1, 7, 14 and were followed
3 months. At D-15 patients were examined and X-rays were performed,
in order to exclude patients with bilateral K-OA, or those with more than
3 OA joints including the target knee. From D-15 to D90 concomitant
therapies were unchanged. Walking pain (WP) on VAS was obtained
at each visit. Clinical response was deﬁned as a WP decrease >50%
between D1 and D90. S (S) samples were obtained, using a standardized
procedure, 2 weeks before the ﬁrst injection (D-15), then at D1 (1st
injection), D30 and D90. Coll2–1 and Coll2–1NO2 were measured directly
in the serum using speciﬁc immunoassays. Variations over time for
each biomarker were studied using Wilcoxon rank sum test. Predictive
factors of response were analyzed using univariate comparison and
logistic regression. Correlations between variables were obtained using
Spearman test.
Results: 45 patients (mean age 57.7, mean BMI 26.7) were analyzed.
Between D-15 and D1 there was no signiﬁcant difference for sColl2–1 and
sColl2–1NO2 biomarkers (all p > 0.05), indicating a good reproducibility
in serum measurements and the absence of spontaneous variation over
time. At D1, sColl2–1 and sColl2–1NO2 were unrelated to age, sex,
BMI, disease duration and WP. However, sColl2–1 and sColl2–1NO2
were signiﬁcantly higher in KL III/IV OA group than in KL I/II group
(p < 0.01). Variation of the biomarkers over time: Coll2–1 and Coll2–1NO2
decreased systematically and signiﬁcantly over time (Coll2–1/D1-D30:
p =0.0002; D1-D90: p =0.054; Coll2–1NO2/D1-D30: p =0.04; D1-D90:
p =0.025). The effect of HA was observed only in patients with the
most severe OA (KL III/IV). sColl2–1 at baseline was signiﬁcantly lower
in responders than in non responders (139.8(34.8) versus 167(45.1);
p = 0.03) even after adjustment for age, BMI and KL grade.
Conclusions: This study suggests a rapid slowdown of type II
collagen degradation and joint inﬂammation after viscosupplementation
with hylan GF-20. Coll2–1 and Coll2–1NO2 serum levels signiﬁcantly
decrease compared to baseline especially in patients with advanced
OA. Long term prospective trials are required to conﬁrm this potential
chondroprotective effect of HA.
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Purpose: The association between osteoarthritis (OA) biomarkers and
lumbar spine individual radiographic features (IRF) has received little
investigation in the literature. Results have been conﬂicting regarding
the association between urinary cross-linked C-telopeptide of type II
collagen (uCTX-II) and disc space narrowing (DSN), and no association
has been found between uCTX-II and osteophytes (OST). No studies
have examined the association between lumbar spine IRF and serum
hyaluronan (sHA). Therefore, the two primary purposes of these analyses
were to: 1) determine if levels of uCTX-II and sHA reﬂect the presence
and severity of DSN and OST, controlling for the presence of knee OA
and 2) determine if these associations differ by gender or race.
Methods: Of the 1,015 participants enrolled in the Johnston County OA
Project from 2003–2004, lumbar spine IRF (DSN and OST) were available
for 547 participants with complete sHA data and 529 participants with
complete uCTX-II data (mean age 62.3 (SD 9.9), 61.8% female, 37.8%
African American, mean body mass index (BMI) 30.1 (SD 6.2), 29.2%
knee OA). Each lumbar spine level was graded in a semi-quantitative
fashion (0–3) according to the Burnett Atlas. From these grades, a
summary score from the ﬁve lumbar levels was developed separately
for each IRF (DSN and OST). The geometric mean and 95% conﬁdence
interval (CI) of uCTX-II and sHA levels were calculated across severity of
DSN and OST. Proportional odds and partial proportional odds models
were used to determine associations of DSN and OST severity with sHA
and uCTX-II. All analyses were adjusted for age, gender, race, BMI and
concomitant radiographic knee OA deﬁned as Kellgren-Lawrence score
of 2–4. Interactions were tested with likelihood ratio tests (p< 0.10) to
determine if associations differed signiﬁcantly by gender or race.
Results: Mean levels of uCTX-II increased with both severity of DSN
(p =0.002) and OST (p < 0.001). After adjustment, a one unit change
in uCTX-II was associated with 63% higher odds of more severe DSN
[adjusted odds ratio (aOR) = 1.63 (95% CI 1.27, 2.10)]. A strong association
was also seen for uCTX-II and the highest category of OST severity (aOR
= 3.24 (95% CI 1.89, 5.54).
In contrast, mean levels of sHA increased across severity of DSN
(p =0.010), whereas there was no association across severity of OST
(p =0.139). After adjustment, each one unit change in sHA, was associated
with increasing severity levels of DSN with ORs from 1.12 (95% CI 0.93,
1.35), 1.43 (95% CI 1.12, 1.83) and 2.25 (95% CI 1.51, 3.37). This effect was
predominantly seen in women (aOR = 1.34 (95% CI 1.09, 1.65), whereas
the association among men was close to the null (OR 0.95, (95% CI 0.68,
1.33). The association between sHA and OST severity was weak and of
borderline statistical signiﬁcance (aOR = 1.16 (95% CI 0.97, 1.38).
There effects were similar in both African Americans and Caucasians.
Conclusions: uCTX-II levels reﬂected increasing severity of lumbar DSN
and OST, above and beyond known associations between uCTX-II and
radiographic knee OA. This is the ﬁrst study to demonstrate that levels
of sHA differ according to severity of lumbar DSN, but are only weakly
associated with severity of lumbar OST. These ﬁndings underscore the
importance of analyzing IRFs for revealing biological insights through
biomarker studies.
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Purpose: Individuals who sustain a complete rupture of the anterior
cruciate ligament (ACL) are 40–80% more likely to also experience
subsequent degradation of tibiofemoral articular cartilage during the
years following injury regardless of surgical or non-surgical intervention.
The clinical corollary for this condition is early-onset post-traumatic
osteoarthritis (PTOA). Radiographic techniques serve as the current gold
standard for detecting the onset and monitoring the progression of
PTOA. Although these techniques are limited, they serve as a vital
research tool to monitor gross structural changes while attempting to
elucidate the pathophysiology of PTOA. The evaluation of biochemical
markers indicative of type-II collagen turnover in serum and urine is
thought to provide insight into the pathophysiology of the osteoarthritic
joint. Consequently, a substantial effort is underway to discover and
validate biomarkers that have the potential to overcome the limitations of
radiography, and help predict and/or monitor the onset and progression
of PTOA. The purpose of this investigation was to assess whether
levels of serum- and/or urine-based molecular markers of type-II
collagen metabolism are associated with joint space width change
(compared to the normal, contralateral limb, as well as to healthy control
subjects) 4 years following anterior cruciate ligament (ACL) injury and
reconstruction (ACL-R).
Methods: A prospective cohort with nested case-control study design
was used to evaluate markers of type-II collagen metabolism in 35
(18 women) ACL-R and 32 healthy matched control subjects (15 women)
of similar age, race, BMI, and activity level. Weight-bearing bilateral
AP view knee x-rays were obtained 1 and 4 year-post-ACL-R intervals;
and joint space width (JSW) determined using previously validated
techniques. Subjects were considered to have signiﬁcant JSW differences
(JSW-D) of their injured knee if the injured minus normal (contralateral)
knee difference fell outside ±2 standard deviations (SD) of the side-to-
side difference measured in controls. Serum and urine samples were
collected at each time point for the purpose of evaluating markers
of type-II collagen metabolism. Urinary degradation markers included
collagenase cleavage products of type II collagen (uC2C & uC1–2C
epitopes) and C-terminal cross-linked telopeptide of type-II collagen
(uCTX-II). Serum was obtained for the evaluation of the synthesis
marker C-propeptide of type II collagen (sCPII). These markers were
evaluated via commercially available enzyme-linked immunosorbent
